Onward Medical N.V. Cash Flow Conversion Efficiency
Onward Medical N.V. cash flow conversion efficiency. Based on the latest financial reports, Onward Medical N.V. (ONWD) has a cash flow conversion efficiency ratio of -0.366x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.25 Million ≈ $-23.68 Million USD) by net assets (€55.32 Million ≈ $64.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Onward Medical N.V. (2018–2025)
Cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2025. This chart illustrates how Onward Medical N.V.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Onward Medical N.V. (ONWD) stock price for real-time trading data and today's change.
Onward Medical N.V. Cash Flow Conversion Ratio Explained
Onward Medical N.V. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Onward Medical N.V. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Onward Medical N.V. ranked by their cash flow conversion efficiency. Also see Onward Medical N.V. (ONWD) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wasko S.A.
WAR:WAS
|
0.045x |
|
Donga Geologic
KO:028100
|
0.106x |
|
SFP Tech Holdings Bhd
KLSE:0251
|
0.021x |
|
Curexo Inc
KQ:060280
|
-0.016x |
|
Black Spade Acquisition II Co
NASDAQ:BSII
|
-0.002x |
|
Starpharma Holdings Ltd
AU:SPL
|
-0.517x |
|
TONT
NYSE MKT:TONT
|
0.000x |
|
BriQ Properties Real Estate Investment Company
AT:BRIQ
|
0.005x |
Annual Cash Flow Conversion Efficiency for Onward Medical N.V. (2018–2025)
The table below shows the annual cash flow conversion efficiency of Onward Medical N.V. from 2018 to 2025. Review Onward Medical N.V. (ONWD) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €55.32 Million ≈ $64.67 Million |
€-39.07 Million ≈ $-45.67 Million |
-0.706x | -6.85% |
| 2024-12-31 | €48.05 Million ≈ $56.18 Million |
€-31.76 Million ≈ $-37.13 Million |
-0.661x | +63.27% |
| 2023-12-31 | €17.93 Million ≈ $20.96 Million |
€-32.27 Million ≈ $-37.73 Million |
-1.800x | -254.95% |
| 2022-12-31 | €52.63 Million ≈ $61.53 Million |
€-26.68 Million ≈ $-31.20 Million |
-0.507x | -110.94% |
| 2021-12-31 | €82.68 Million ≈ $96.67 Million |
€-19.87 Million ≈ $-23.23 Million |
-0.240x | -159.80% |
| 2020-12-31 | €-32.09 Million ≈ $-37.52 Million |
€-12.90 Million ≈ $-15.08 Million |
0.402x | -39.07% |
| 2019-12-31 | €-14.92 Million ≈ $-17.45 Million |
€-9.85 Million ≈ $-11.51 Million |
0.660x | -5.33% |
| 2018-12-31 | €-10.27 Million ≈ $-12.01 Million |
€-7.16 Million ≈ $-8.37 Million |
0.697x | -- |
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more